Bantas, Acas M.
HRN: 04-41-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/06/2024
02/13/2024
IV
2.25gm
Q6H
Abdominal Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes